PRAMIPEXOLE GPPL pramipexole dihydrochloride 0.5 mg tablets blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

pramipexole dihydrochloride monohydrate, Quantity: 0.5 mg

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

pramipexole dihydrochloride monohydrate

pharmaceutical_form:

Tablet, uncoated

composition:

Excipient Ingredients: pregelatinised maize starch; mannitol; magnesium stearate; povidone; silicon dioxide

administration_route:

Oral

units_in_package:

10, 30, 100

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

leaflet_short:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '4' debossed on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

authorization_status:

Licence status A

authorization_date:

2014-09-23